<table width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 25:  Clinically Important Drug Interactions with ABILIFY:</caption>
<col width="20%"></col>
<col width="36%"></col>
<col width="36%"></col>
<tbody>
<tr>
<td align="center" stylecode="Rrule Botrule Lrule Toprule ">
<paragraph>Concomitant Drug Name or Drug Class</paragraph>
</td>
<td align="center" stylecode="Rrule Botrule Lrule Toprule ">
<paragraph>Clinical Rationale</paragraph>
</td>
<td align="center" stylecode="Rrule Botrule Lrule Toprule ">
<paragraph>Clinical Recommendation</paragraph>
</td>
</tr>
<tr>
<td align="left" stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>Strong CYP3A4 Inhibitors (e.g., itraconazole, clarithromycin) or strong CYP2D6 inhibitors (e.g., quinidine, fluoxetine, paroxetine)</paragraph>
</td>
<td align="left" stylecode="Rrule Lrule Toprule Botrule " valign="middle">
<paragraph>The concomitant use of ABILIFY with strong CYP 3A4 or CYP2D6 inhibitors increased the exposure of aripiprazole compared to the use of ABILIFY alone <content stylecode="italics">[see <linkhtml href="#ID_82e3f93b-5cc7-4f94-8229-e6cc389b6870">CLINICAL PHARMACOLOGY (12.3)</linkhtml>].</content>
</paragraph>
</td>
<td align="left" stylecode="Rrule Lrule Toprule Botrule " valign="middle">
<paragraph>With concomitant use of ABILIFY with a strong CYP3A4 inhibitor or CYP2D6 inhibitor, reduce the ABILIFY dosage  <content stylecode="italics">[see <linkhtml href="#ID_0dbbe393-b0f1-4525-bb18-7d15010d47fb">DOSAGE AND ADMINISTRATION (2.7)</linkhtml>]</content>.  </paragraph>
</td>
</tr>
<tr>
<td align="left" stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>Strong CYP3A4 Inducers (e.g., carbamazepine, rifampin)</paragraph>
</td>
<td align="left" stylecode="Rrule Lrule Toprule Botrule " valign="middle">
<paragraph>The concomitant use of ABILIFY and carbamazepine decreased the exposure of aripiprazole compared to the use of ABILIFY alone <content stylecode="italics">[see <linkhtml href="#ID_82e3f93b-5cc7-4f94-8229-e6cc389b6870">CLINICAL PHARMACOLOGY (12.3)</linkhtml>]</content>.</paragraph>
</td>
<td align="left" stylecode="Rrule Lrule Toprule Botrule " valign="middle">
<paragraph>With concomitant use of ABILIFY with a strong CYP3A4 inducer, consider increasing the ABILIFY dosage <content stylecode="italics">[see <linkhtml href="#ID_0dbbe393-b0f1-4525-bb18-7d15010d47fb">DOSAGE AND ADMINISTRATION (2.7)</linkhtml>]</content>.  </paragraph>
</td>
</tr>
<tr>
<td align="left" stylecode="Rrule Lrule Botrule " valign="middle">
<paragraph>Antihypertensive Drugs</paragraph>
</td>
<td align="left" stylecode="Rrule Lrule Toprule Botrule " valign="middle">
<paragraph>Due to its alpha adrenergic antagonism, aripiprazole has the potential to enhance the effect of certain antihypertensive agents.</paragraph>
</td>
<td align="left" stylecode="Rrule Lrule Toprule Botrule " valign="middle">
<paragraph>Monitor blood pressure and adjust dose accordingly <content stylecode="italics">[see <linkhtml href="#ID_2ca71f94-9e79-4a1d-8aba-74f6e23ea703">WARNINGS AND PRECAUTIONS (5.7)</linkhtml>]</content>.</paragraph>
</td>
</tr>
<tr>
<td align="left" stylecode="Rrule Botrule Lrule Toprule " valign="middle">
<paragraph>Benzodiazepines (e.g., lorazepam)</paragraph>
</td>
<td align="left" stylecode="Rrule Botrule Lrule Toprule " valign="middle">
<paragraph>The intensity of sedation was greater with the combination of oral aripiprazole and lorazepam as compared to that observed with aripiprazole alone. The orthostatic hypotension observed was greater with the combination as compared to that observed with lorazepam alone <content stylecode="italics">[see <linkhtml href="#ID_2ca71f94-9e79-4a1d-8aba-74f6e23ea703">WARNINGS AND PRECAUTIONS (5.7)</linkhtml>]</content>
</paragraph>
</td>
<td align="left" stylecode="Rrule Botrule Lrule Toprule " valign="middle">
<paragraph>Monitor sedation and blood pressure. Adjust dose accordingly.</paragraph>
</td>
</tr>
</tbody>
</table>